Although the stock market was having a generally strong week, that isn't the case for vaccine technology company Moderna ...
CDC officials said they opted to upgrade the advisory after seeing more patients whose illness cannot be traced back to an infected animal or bird. "That's a newer finding in the history of H5 - not ...
President Joe Biden's outgoing administration on Thursday announced $211 million in new funding to develop mRNA vaccines ...
Dame Tracey Emin and Sir Grayson Perry are celebrated with solo exhibitions at the suitably palatial Palazzo Strozzi in ...
Hosted on MSN2h
Biotech Stock Roundup: MRNA, NTLA Down on Updates, SAGE Up on Biogen's Offer & Other UpdatesIt was an extremely busy week in the biotech sector, with several companies making important presentations at the J.P. Morgan ...
Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...
Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market ...
Moderna (NASDAQ: MRNA) shareholders have been having a rough time lately. The biotech stock rocketed higher last spring, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback